Drug Side-Effect Prediction via Clinical Correlation Engine

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing computational methods for predicting drug side-effects and therapeutic indications are limited by translational issues and noise from off-target binding, and current associations are biased and insufficient in number.

Innovation Solution

A system and method that uses classifiers to predict whether a chemical treats a particular indication or causes a side-effect, determining correlations between indications and side-effects using a correlation engine, and visualizing these correlations for analysis, employing clinical data and properties like chemical structures and protein targets.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If computational methods use preclinical information (chemical structures or protein targets) to predict drug indications, then prediction can be performed, but clinical therapeutic effects are not always consistent with preclinical outcomes due to translational issues and off-target binding noise

Engineering Contradiction:
Improveprediction accuracyVSAvoidclinical consistency
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent introduces side-effect profiles as an intermediary element to bridge preclinical chemical/biological information and clinical therapeutic effects. By using side-effect data from clinical observations as a mediator, the system connects drug properties to disease indications through clinically validated pathways, reducing the translational gap between preclinical predictions and clinical outcomes.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The system incorporates feedback from clinical side-effect observations to refine indication predictions. By continuously integrating real-world clinical data about side effects into the prediction model, the system learns from actual clinical outcomes rather than relying solely on preclinical data, improving both accuracy and reliability over time.

Inventive Principle:
Principle #23Feedback

2Quantity of substance

If disease-side-effect associations are built based on all known drug-disease and drug-side-effect information, then associations can be generated, but the associations are very limited in number and biased from current observations

Engineering Contradiction:
Improvenumber of associationsVSAvoidassociation bias
Core Design Contradiction:
Quantity of substanceVSLoss of information

Solution Approach 1:

The system performs preliminary enrichment of side-effect profiles by integrating multiple data sources and preprocessing clinical observation data before building associations. This preliminary action ensures that the foundation data is comprehensive and de-biased, allowing subsequent association generation to produce more numerous and less biased disease-side-effect relationships.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent employs multiple computational methods and data sources (chemical structures, protein targets, phenotypic profiles, and clinical observations) to build side-effect profiles. This multi-functional approach allows the system to generate associations from diverse information types, increasing the quantity of associations while reducing bias through methodological diversity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Ease of manufacture

If existing methods focus on chemical structures or protein targets, then preclinical prediction is enabled, but off-target binding occurs causing noise and translational issues

Engineering Contradiction:
Improveprediction feasibilityVSAvoidoff-target binding noise
Core Design Contradiction:
Ease of manufactureVSObject-generated harmful factors

Solution Approach 1:

The patent converts the harmful effect of off-target binding into a beneficial signal by using observed side effects as informative features for prediction. Instead of treating off-target binding as noise to be eliminated, the system leverages it as clinically relevant information that reflects actual drug behavior in patients, transforming a problem into a solution.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Data Source

PatentUS10692588B2Method and system for exploring the associations between drug side-effects and therapeutic indications
Publication Date: 2020.06.23 INTERNATIONAL BUSINESS MACHINE CORPORATION
  • US10692588B2 patent drawing
  • US10692588B2 patent drawing
  • US10692588B2 patent drawing

AI summary

A system and method for analyzing chemical data including a processor and one or more classifiers, stored in memory and coupled to the processor, which further includes an indication predictive module configured to predict whether a given chemical treats a particular indication or not and a side effect predictive module configured to predict whether a given chemical causes a side-effect or not. A correlation engine is configured to determine one or more correlations between one or more indications and one or more side effects for the given chemical and a visualization tool is configured to analyze the one or more correlations and to output results of the analysis.